Literature DB >> 26773157

Kras Is Critical for B Cell Lymphopoiesis.

Yuhong Chen1, Yongwei Zheng1, Xiaona You2, Mei Yu1, Guoping Fu1, Xinlin Su3, Fen Zhou4, Wen Zhu1, Zhihong Wu5, Jing Zhang2, Renren Wen1, Demin Wang6.   

Abstract

The three major Ras members, Kras, Hras, and Nras, are highly homologous and individual Ras genes can have distinct biological functions. Embryonic lethality of Kras-deficient mice precludes study of the biological functions of this Ras family member. In this study, we generated and examined mice with hematopoietic-specific deletion of Kras and bone marrow (BM) chimeric mice with B cell-specific targeted deletion of Kras. Hematopoietic-specific deletion of Kras impaired early B cell development at the pre-B cell stage and late B cell maturation, resulting in the reduction of BM pre-, immature, and mature B cells and peripheral follicular, marginal zone, and B1 mature B cells. In contrast, Kras deficiency did not affect T cell development. Studies of BM chimeric mice with B cell-specific deletion of Kras demonstrated that Kras deficiency intrinsically impaired B cell development. Kras deficiency reduced BCR-induced B cell proliferation and survival. Furthermore, Kras deficiency specifically impaired pre-BCR- and BCR-induced activation of the Raf-1/MEK/ERK pathway in pre-B and mature B cells, respectively. Thus, Kras is the unique Ras family member that plays a critical role in early B cell development and late B cell maturation through controlling the Raf-1/MEK/ERK pathway.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26773157      PMCID: PMC4744498          DOI: 10.4049/jimmunol.1502112

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  GTP-dependent segregation of H-ras from lipid rafts is required for biological activity.

Authors:  I A Prior; A Harding; J Yan; J Sluimer; R G Parton; J F Hancock
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

Review 2.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Distinct mechanisms determine the patterns of differential activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by receptors for growth factors or antigen.

Authors:  Annette Ehrhardt; Muriel D David; Götz R A Ehrhardt; John W Schrader
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

4.  Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development.

Authors:  L M Esteban; C Vicario-Abejón; P Fernández-Salguero; A Fernández-Medarde; N Swaminathan; K Yienger; E Lopez; M Malumbres; R McKay; J M Ward; A Pellicer; E Santos
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Mice deficient for N-ras: impaired antiviral immune response and T-cell function.

Authors:  Ignacio Pérez de Castro; Roberto Diaz; Marcos Malumbres; María-Inmaculada Hernández; Jaishree Jagirdar; María Jiménez; Daniel Ahn; Angel Pellicer
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

Review 6.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway.

Authors:  A Apolloni; I A Prior; M Lindsay; R G Parton; J F Hancock
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

8.  Raf-1 activates MAP kinase-kinase.

Authors:  J M Kyriakis; H App; X F Zhang; P Banerjee; D L Brautigan; U R Rapp; J Avruch
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

9.  N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation.

Authors:  Salvador Iborra; Manuel Ramos; David M Arana; Silvia Lázaro; Francisco Aguilar; Eugenio Santos; Daniel López; Edgar Fernández-Malavé; Margarita Del Val
Journal:  J Exp Med       Date:  2013-06-17       Impact factor: 14.307

10.  Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase C-gamma2 to Ras in B cell receptor signaling.

Authors:  Masatsugu Oh-hora; Sachiko Johmura; Ari Hashimoto; Masaki Hikida; Tomohiro Kurosaki
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  11 in total

1.  Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.

Authors:  Wenwen Xu; Juan Dong; Yongwei Zheng; Juan Zhou; Ying Yuan; Hieu Minh Ta; Halli E Miller; Michael Olson; Kamalakannan Rajasekaran; Marc S Ernstoff; Demin Wang; Subramaniam Malarkannan; Li Wang
Journal:  Cancer Immunol Res       Date:  2019-07-24       Impact factor: 11.151

2.  MLL1 Promotes IL-7 Responsiveness and Survival during B Cell Differentiation.

Authors:  Tao Gan; Bin E Li; Bibhu P Mishra; Kenneth L Jones; Patricia Ernst
Journal:  J Immunol       Date:  2018-01-19       Impact factor: 5.422

Review 3.  The mystery of oncogenic KRAS: Lessons from studying its wild-type counter part.

Authors:  Yuan-I Chang; Alisa Damnernsawad; Guangyao Kong; Xiaona You; Demin Wang; Jing Zhang
Journal:  Small GTPases       Date:  2016-07-22

4.  Kras is Required for Adult Hematopoiesis.

Authors:  Alisa Damnernsawad; Guangyao Kong; Zhi Wen; Yangang Liu; Adhithi Rajagopalan; Xiaona You; Jinyong Wang; Yun Zhou; Erik A Ranheim; Hongbo R Luo; Qiang Chang; Jing Zhang
Journal:  Stem Cells       Date:  2016-03-28       Impact factor: 6.277

5.  Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity.

Authors:  Lan Luo; Yuhong Chen; Xiao Chen; Yongwei Zheng; Vivian Zhou; Mei Yu; Robert Burns; Wen Zhu; Guoping Fu; Juan C Felix; Christopher Hartley; Alisa Damnernsawad; Jing Zhang; Renren Wen; Williams R Drobyski; Chunji Gao; Demin Wang
Journal:  J Immunol       Date:  2020-11-06       Impact factor: 5.422

6.  KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy.

Authors:  Rosamaria Pinto; Daniela Petriella; Rosanna Lacalamita; Michele Montrone; Annamaria Catino; Pamela Pizzutilo; Maria Antonietta Botticella; Francesco Alfredo Zito; Gabriella Del Bene; Antonia Zonno; Stefania Tommasi; Simona De Summa
Journal:  Cancers (Basel)       Date:  2019-08-09       Impact factor: 6.639

7.  Syk degradation restrains plasma cell formation and promotes zonal transitions in germinal centers.

Authors:  Natalia Davidzohn; Adi Biram; Liat Stoler-Barak; Amalie Grenov; Bareket Dassa; Ziv Shulman
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

8.  Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.

Authors:  Zhi Wen; Grant Yun; Alexander Hebert; Guangyao Kong; Erik A Ranheim; Remington Finn; Adhithi Rajagoplan; Shuyi Li; Yun Zhou; Mei Yu; Alisa Damnernsawad; Jeroen P Roose; Joshua J Coon; Renren Wen; Demin Wang; Jing Zhang
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

Review 9.  Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation.

Authors:  Thomas Yul Avery; Natalie Köhler; Robert Zeiser; Tilman Brummer; Dietrich Alexander Ruess
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

10.  Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.

Authors:  Simar Pal Singh; Marjolein J W de Bruijn; Mariana P de Almeida; Ruud W J Meijers; Lars Nitschke; Anton W Langerak; Saravanan Y Pillai; Ralph Stadhouders; Rudi W Hendriks
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.